557 related articles for article (PubMed ID: 12829994)
1. Central role of PPARalpha-dependent hepatic lipid turnover in dietary steatohepatitis in mice.
Ip E; Farrell GC; Robertson G; Hall P; Kirsch R; Leclercq I
Hepatology; 2003 Jul; 38(1):123-32. PubMed ID: 12829994
[TBL] [Abstract][Full Text] [Related]
2. Administration of the potent PPARalpha agonist, Wy-14,643, reverses nutritional fibrosis and steatohepatitis in mice.
Ip E; Farrell G; Hall P; Robertson G; Leclercq I
Hepatology; 2004 May; 39(5):1286-96. PubMed ID: 15122757
[TBL] [Abstract][Full Text] [Related]
3. Activation of peroxisome proliferator-activated receptor alpha by dietary fish oil attenuates steatosis, but does not prevent experimental steatohepatitis because of hepatic lipoperoxide accumulation.
Larter CZ; Yeh MM; Cheng J; Williams J; Brown S; dela Pena A; Bell-Anderson KS; Farrell GC
J Gastroenterol Hepatol; 2008 Feb; 23(2):267-75. PubMed ID: 17868330
[TBL] [Abstract][Full Text] [Related]
4. Elevated basal expression of liver peroxisomal beta-oxidation enzymes and CYP4A microsomal fatty acid omega-hydroxylase in STAT5b(-/-) mice: cross-talk in vivo between peroxisome proliferator-activated receptor and signal transducer and activator of transcription signaling pathways.
Zhou YC; Davey HW; McLachlan MJ; Xie T; Waxman DJ
Toxicol Appl Pharmacol; 2002 Jul; 182(1):1-10. PubMed ID: 12127257
[TBL] [Abstract][Full Text] [Related]
5. CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis.
Leclercq IA; Farrell GC; Field J; Bell DR; Gonzalez FJ; Robertson GR
J Clin Invest; 2000 Apr; 105(8):1067-75. PubMed ID: 10772651
[TBL] [Abstract][Full Text] [Related]
6. Peroxisome proliferator-activated receptor alpha controls the hepatic CYP4A induction adaptive response to starvation and diabetes.
Kroetz DL; Yook P; Costet P; Bianchi P; Pineau T
J Biol Chem; 1998 Nov; 273(47):31581-9. PubMed ID: 9813074
[TBL] [Abstract][Full Text] [Related]
7. Drug metabolizing enzyme induction pathways in experimental non-alcoholic steatohepatitis.
Fisher CD; Jackson JP; Lickteig AJ; Augustine LM; Cherrington NJ
Arch Toxicol; 2008 Dec; 82(12):959-64. PubMed ID: 18488193
[TBL] [Abstract][Full Text] [Related]
8. Peroxisome proliferator-activated receptor alpha mediates the effects of high-fat diet on hepatic gene expression.
Patsouris D; Reddy JK; Müller M; Kersten S
Endocrinology; 2006 Mar; 147(3):1508-16. PubMed ID: 16357043
[TBL] [Abstract][Full Text] [Related]
9. NF-kappaB activation, rather than TNF, mediates hepatic inflammation in a murine dietary model of steatohepatitis.
Dela Peña A; Leclercq I; Field J; George J; Jones B; Farrell G
Gastroenterology; 2005 Nov; 129(5):1663-74. PubMed ID: 16285964
[TBL] [Abstract][Full Text] [Related]
10. CCAAT/enhancing binding protein beta deletion in mice attenuates inflammation, endoplasmic reticulum stress, and lipid accumulation in diet-induced nonalcoholic steatohepatitis.
Rahman SM; Schroeder-Gloeckler JM; Janssen RC; Jiang H; Qadri I; Maclean KN; Friedman JE
Hepatology; 2007 May; 45(5):1108-17. PubMed ID: 17464987
[TBL] [Abstract][Full Text] [Related]
11. Peroxisomal and mitochondrial fatty acid beta-oxidation in mice nullizygous for both peroxisome proliferator-activated receptor alpha and peroxisomal fatty acyl-CoA oxidase. Genotype correlation with fatty liver phenotype.
Hashimoto T; Fujita T; Usuda N; Cook W; Qi C; Peters JM; Gonzalez FJ; Yeldandi AV; Rao MS; Reddy JK
J Biol Chem; 1999 Jul; 274(27):19228-36. PubMed ID: 10383430
[TBL] [Abstract][Full Text] [Related]
12. Effects of bezafibrate, PPAR pan-agonist, and GW501516, PPARdelta agonist, on development of steatohepatitis in mice fed a methionine- and choline-deficient diet.
Nagasawa T; Inada Y; Nakano S; Tamura T; Takahashi T; Maruyama K; Yamazaki Y; Kuroda J; Shibata N
Eur J Pharmacol; 2006 Apr; 536(1-2):182-91. PubMed ID: 16574099
[TBL] [Abstract][Full Text] [Related]
13. Polyunsaturated fatty acid suppression of hepatic fatty acid synthase and S14 gene expression does not require peroxisome proliferator-activated receptor alpha.
Ren B; Thelen AP; Peters JM; Gonzalez FJ; Jump DB
J Biol Chem; 1997 Oct; 272(43):26827-32. PubMed ID: 9341113
[TBL] [Abstract][Full Text] [Related]
14. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
[TBL] [Abstract][Full Text] [Related]
15. Peroxisome proliferator-activated receptor-α agonist, Wy 14,643, improves metabolic indices, steatosis and ballooning in diabetic mice with non-alcoholic steatohepatitis.
Larter CZ; Yeh MM; Van Rooyen DM; Brooling J; Ghatora K; Farrell GC
J Gastroenterol Hepatol; 2012 Feb; 27(2):341-50. PubMed ID: 21929649
[TBL] [Abstract][Full Text] [Related]
16. Oxidized frying oil up-regulates hepatic acyl-CoA oxidase and cytochrome P450 4 A1 genes in rats and activates PPARalpha.
Chao PM; Chao CY; Lin FJ; Huang C
J Nutr; 2001 Dec; 131(12):3166-74. PubMed ID: 11739861
[TBL] [Abstract][Full Text] [Related]
17. Phyllanthus urinaria ameliorates the severity of nutritional steatohepatitis both in vitro and in vivo.
Shen B; Yu J; Wang S; Chu ES; Wong VW; Zhou X; Lin G; Sung JJ; Chan HL
Hepatology; 2008 Feb; 47(2):473-83. PubMed ID: 18157836
[TBL] [Abstract][Full Text] [Related]
18. The role of the nuclear receptor constitutive androstane receptor in the pathogenesis of non-alcoholic steatohepatitis.
Yamazaki Y; Kakizaki S; Horiguchi N; Sohara N; Sato K; Takagi H; Mori M; Negishi M
Gut; 2007 Apr; 56(4):565-74. PubMed ID: 16950832
[TBL] [Abstract][Full Text] [Related]
19. COX-2 induction in mice with experimental nutritional steatohepatitis: Role as pro-inflammatory mediator.
Yu J; Ip E; Dela Peña A; Hou JY; Sesha J; Pera N; Hall P; Kirsch R; Leclercq I; Farrell GC
Hepatology; 2006 Apr; 43(4):826-36. PubMed ID: 16557554
[TBL] [Abstract][Full Text] [Related]
20. Elevated free cholesterol in a p62 overexpression model of non-alcoholic steatohepatitis.
Simon Y; Kessler SM; Gemperlein K; Bohle RM; Müller R; Haybaeck J; Kiemer AK
World J Gastroenterol; 2014 Dec; 20(47):17839-50. PubMed ID: 25548482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
